{"log_id": 53059511192142290, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0, "average": 0.999661, "min": 0.99856}, "location": {"width": 310, "top": 193, "height": 26, "left": 255}, "words": "出现视觉的改变时,应当通知医生"}, {"probability": {"variance": 2e-06, "average": 0.99936, "min": 0.994216}, "location": {"width": 354, "top": 227, "height": 25, "left": 253}, "words": "如果患者有癫痫发作病史应当告知医生"}, {"probability": {"variance": 1.2e-05, "average": 0.998811, "min": 0.98202}, "location": {"width": 798, "top": 259, "height": 27, "left": 250}, "words": "腹泻是抗生素导致的常见问题,通常随着抗生素停用而停止。有时在抗生素治疗开始后"}, {"probability": {"variance": 2e-06, "average": 0.999343, "min": 0.991333}, "location": {"width": 852, "top": 293, "height": 30, "left": 209}, "words": "患者可能发生水样便或血便(伴或不伴胃痉挛和发热),甚至有可能在停用抗生素后2月或超"}, {"probability": {"variance": 3e-06, "average": 0.999065, "min": 0.993007}, "location": {"width": 531, "top": 329, "height": 26, "left": 208}, "words": "过2月后发生。如发生上述情况,患者应尽快与医生联系"}, {"probability": {"variance": 5e-06, "average": 0.999014, "min": 0.990148}, "location": {"width": 812, "top": 359, "height": 32, "left": 249}, "words": "应告知患者抗菌药物包括利奈唑胺应仅用于治疗细菌感染,而不应当用于治疗病毒感染"}, {"probability": {"variance": 8e-06, "average": 0.998874, "min": 0.984}, "location": {"width": 833, "top": 394, "height": 29, "left": 229}, "words": "如:感冒)。当利奈唑胺用于细菌感染时,应告知患者在治疗的早期,虽然患者通常会感觉"}, {"probability": {"variance": 7.9e-05, "average": 0.997407, "min": 0.945456}, "location": {"width": 855, "top": 428, "height": 27, "left": 207}, "words": "好转,仍应当按照医嘱准确服药。用药的疏漏或没有完成整个治疗过程,可能会(1)降低当"}, {"probability": {"variance": 2e-06, "average": 0.999265, "min": 0.993305}, "location": {"width": 856, "top": 460, "height": 28, "left": 206}, "words": "时的治疗效果且(2)增加细菌耐药的发生,以及将来可能不能应用利奈唑胺或其他抗菌药物"}, {"probability": {"variance": 0, "average": 0.999986, "min": 0.999974}, "location": {"width": 43, "top": 498, "height": 23, "left": 206}, "words": "治疗"}, {"probability": {"variance": 0.005153, "average": 0.983016, "min": 0.646678}, "location": {"width": 471, "top": 528, "height": 28, "left": 205}, "words": "药物相互作用(见【药理毒理】、【药物相互作用】"}, {"probability": {"variance": 1.7e-05, "average": 0.997739, "min": 0.981784}, "location": {"width": 856, "top": 558, "height": 31, "left": 206}, "words": "单胺氧化酶抑制作用:利奈唑胺为一可逆的、非选择性的单胺氧化酶抑制剂。所以,利奈唑"}, {"probability": {"variance": 0.007018, "average": 0.982284, "min": 0.571898}, "location": {"width": 514, "top": 594, "height": 26, "left": 204}, "words": "胺与类肾上腺素能和5-羟色胺类药物有潜在的相互作用"}, {"probability": {"variance": 1.1e-05, "average": 0.998721, "min": 0.981144}, "location": {"width": 858, "top": 656, "height": 32, "left": 205}, "words": "肾上腺素能类药物:有些患者接受利奈唑胺可能使非直接作用的拟交感神经药物、血管加压"}, {"probability": {"variance": 1.9e-05, "average": 0.998118, "min": 0.972466}, "location": {"width": 856, "top": 689, "height": 31, "left": 204}, "words": "药或多巴胺类药物的加压作用可逆性地增加。已对其与常用的药物如苯丙醇胺和伪麻黄碱的"}, {"probability": {"variance": 1e-06, "average": 0.999402, "min": 0.995382}, "location": {"width": 860, "top": 723, "height": 28, "left": 203}, "words": "作用进行了研究。肾上腺素能类药物,如多巴胺或肾上腺素的起始剂量应减小,并逐步调整"}, {"probability": {"variance": 1e-06, "average": 0.999459, "min": 0.997182}, "location": {"width": 213, "top": 758, "height": 26, "left": 204}, "words": "至可起理想药效的水平"}, {"probability": {"variance": 0.020834, "average": 0.949352, "min": 0.423147}, "location": {"width": 862, "top": 820, "height": 27, "left": 201}, "words": "5-羟色胺类药物:在期、Ⅱ1期和Ⅱ期的临床研究中,未见利奈唑胺与5-羟色胺类药物合"}, {"probability": {"variance": 0.0005, "average": 0.992018, "min": 0.869613}, "location": {"width": 864, "top": 853, "height": 30, "left": 200}, "words": "用引起5-羟色胺综合征的报道。利奈唑胺合用5-羟色胺类药物,包括抗抑郁药,如:选择性"}, {"probability": {"variance": 0.000379, "average": 0.993463, "min": 0.903059}, "location": {"width": 865, "top": 884, "height": 31, "left": 199}, "words": "5-羟色胺再摄取抑制剂( SSRIS),有5-羟色胺综合征的自发性报告。接受利奈唑胺治疗的患"}, {"probability": {"variance": 0.000413, "average": 0.995335, "min": 0.87756}, "location": {"width": 717, "top": 918, "height": 27, "left": 200}, "words": "者如同时服用5-羟色胺类药物应当按照一般注意事项中的要求进行严密监测。"}, {"probability": {"variance": 3.1e-05, "average": 0.997418, "min": 0.971516}, "location": {"width": 865, "top": 981, "height": 31, "left": 200}, "words": "强CYP450诱导剂:在一项健康志愿者中的研究,利福平和口服利奈唑胺合用导致利奈唑胺"}, {"probability": {"variance": 0.011111, "average": 0.969713, "min": 0.471674}, "location": {"width": 867, "top": 1014, "height": 28, "left": 198}, "words": "的Cmax降低21%,AUC0-12降低32%。这一相互作用的临床意义不明。其它肝酶强诱导剂(如"}, {"probability": {"variance": 5e-06, "average": 0.998844, "min": 0.985646}, "location": {"width": 867, "top": 1047, "height": 31, "left": 198}, "words": "卡马西平、苯妥英、苯巴比妥),可能引起相似或稍轻的变化(见【药理毒理】【药物相互"}, {"probability": {"variance": 1.6e-05, "average": 0.996883, "min": 0.990018}, "location": {"width": 81, "top": 1082, "height": 26, "left": 198}, "words": "作用】)"}, {"probability": {"variance": 2e-06, "average": 0.998877, "min": 0.995762}, "location": {"width": 284, "top": 1146, "height": 26, "left": 196}, "words": "药物与实验室检查的相互影响"}, {"probability": {"variance": 2.5e-05, "average": 0.998082, "min": 0.978414}, "location": {"width": 370, "top": 1179, "height": 27, "left": 238}, "words": "没有关于本品可干扰实验室检查的报道"}, {"probability": {"variance": 1e-06, "average": 0.999237, "min": 0.997743}, "location": {"width": 248, "top": 1244, "height": 26, "left": 202}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 6e-06, "average": 0.998998, "min": 0.9868}, "location": {"width": 828, "top": 1275, "height": 29, "left": 236}, "words": "利奈唑胺及其代谢产物可分泌至哺乳期大鼠的乳汁中。乳汁中的药物浓度与母体的血浆"}, {"probability": {"variance": 9e-06, "average": 0.99856, "min": 0.983127}, "location": {"width": 869, "top": 1309, "height": 29, "left": 193}, "words": "药物浓度相似。利奈唑胺是否分泌至人类的乳汁中尚不明确。由于许多药物都能随人类的乳"}, {"probability": {"variance": 3e-06, "average": 0.998749, "min": 0.994129}, "location": {"width": 413, "top": 1344, "height": 25, "left": 191}, "words": "汁分泌,因此利奈唑胺应慎用于哺乳期妇女"}, {"probability": {"variance": 1e-06, "average": 0.999436, "min": 0.995065}, "location": {"width": 830, "top": 1375, "height": 27, "left": 235}, "words": "尚未在妊娠妇女中进行充分的、严格对照的临床研究。只有潜在的益处超过对胎儿的潜"}, {"probability": {"variance": 1.8e-05, "average": 0.998436, "min": 0.983399}, "location": {"width": 304, "top": 1409, "height": 27, "left": 191}, "words": "在风险时,才建议妊娠妇女应用"}, {"probability": {"variance": 0, "average": 0.999413, "min": 0.998401}, "location": {"width": 122, "top": 1474, "height": 27, "left": 195}, "words": "【儿童用药】"}, {"probability": {"variance": 3.5e-05, "average": 0.998109, "min": 0.963167}, "location": {"width": 834, "top": 1506, "height": 30, "left": 228}, "words": "利奈唑胺用于治疗儿童患者下列感染时的安全性和有效性已得到以下研究的证实,包括在"}, {"probability": {"variance": 0.000175, "average": 0.997537, "min": 0.916112}, "location": {"width": 855, "top": 1538, "height": 29, "left": 188}, "words": "成年人中进行的充分的、严格对照的临床研究、儿童患者的药代动力学研究资料以及在0"}, {"probability": {"variance": 0.000118, "average": 0.996956, "min": 0.936432}, "location": {"width": 879, "top": 1568, "height": 33, "left": 186}, "words": "岁革兰阳性菌感染的儿童中进行的阳性药物对照的临床研究(见【适应症】【用法用量】和"}, {"probability": {"variance": 0.000357, "average": 0.990652, "min": 0.939324}, "location": {"width": 151, "top": 1632, "height": 23, "left": 550}, "words": "第16页,共29页"}, {"probability": {"variance": 0.000626, "average": 0.975166, "min": 0.933224}, "location": {"width": 115, "top": 1659, "height": 20, "left": 567}, "words": "辉瑞——机密"}], "language": 3}